Monthly Archives: July 2022

PAWcast: Valedictorian Natalia Orlovsky ’22 on Research, Mental Health, and Pandemic Princeton – Princeton Alumni Weekly

Posted: July 3, 2022 at 2:33 am

There is no wrong way to do Princeton

Listen onApple PodcastsGoogle PodcastsSpotifySoundcloud

Just a few days before graduating as valedictorian of Princetons Class of 2022, Natalia Orlovsky spoke with PAW about her love for both the sciences and humanities and her hopes for going into academia. As a student she worked in a bioengineering lab, served on the peer review board of thePrinceton Undergraduate Research Journal, was an undergraduate course assistant, served on the board of Theatre Intime, and has been involved with the Gender and Sexuality Resource Center. Her advice to future students is to shrug off the feeling that theres a prescribed arc to their experience, so they can feel like theyre doing Princeton correctly, regardless of how theyre doing Princeton.

TRANSCRIPT:

Carlett Spike:From an early age, Natalia Orlovsky has had a love for both the sciences and humanities. In 2018, while a senior in high school, she was featured in aWashington Postarticle about these two varying interests as she was debating whether to attend Princeton to study science or Oxford to study history. While today Natalia is just a few days shy of graduating from Princeton as the valedictorian for the Class of 2022, she ultimately picked the University because it offered a bit of both. She could study science and explore the humanities through her extracurriculars.

Natalia is a molecular biology concentrator from Chadds Ford, Pennsylvania, and pursuing a certificate in quantitative and computational biology. She has earned 10 A-plus grades in six different departments while at Princeton. Heres a few of things shes done on campus: Natalia has worked in the bioengineering lab of Cliff Brangwynne, served on the peer review board of thePrinceton Undergraduate Research Journal, was an undergraduate course assistant for both Organic Chemistry and Introduction to Data Science, served on the board of Theatre Intime, and has been involved with the Gender and Sexuality Resource Center. Her thesis work studies how two different proteins help determine the physical properties, or squishiness, of the cell nucleus, which in turn influences how easily cells can crawl through narrow passageways.

Im Carlett Spike, PAWs associate editor, and Im here today with Natalia to reflect on her Princeton journey, the lessons shes learned, and her plans for the future.

Welcome, Natalia, and thank you for coming on the PAWcast.

Natalia Orlovsky:Thank you for having me.

CS:Its a pleasure. Congratulations again on this huge accomplishment.

NO:Thank you.

CS:Can you tell us how you first found out and your reaction to the news?

NO:Oh man. So, I got an email from Jill Dolan, cryptically informing me that I should get on a Zoom call with her, and I think I, initially in response was like, Oh man, youre kidding! And she was like, No, Im not. (laughter) And I was like, OK, I see! But, I dont know; its been really overwhelming, and I feel super lucky.

CS:When she reached out, did you know the news was coming, or...

NO:Yeah, so I had a bit of forewarning. (laughs)

CS:OK, nice. So we know why you chose Princeton, for the bit of both worlds, but can you reflect on your journey up until this point and how you were able to take classes in both the sciences and humanities?

NO:Yeah, for sure. I think the main thing that drew me to Princeton was that I could do original research as an undergraduate in particular in the sciences, and so I think Ive spent a lot of time doing my independent work and doing research. Before, I started doing my formal independent work and thats been my primary mode of engagement with science, and then for a lot of my elective coursework, Ive leaned more towards English and theater, and then also Ive been really involved in the student theater community on campus, which have been my main routes of entry to the arts sphere.

CS:Can you talk a little bit more about being involved in the arts while focusing on science and finding time for both, and how you find the balance with it all?

NO:Yeah, for sure. Its interesting because I think there is this sense that most art students focus on the arts in their academic coursework as well, so I guess it is somewhat less common to have STEM folks in performing arts, but there are a lot of people who are. And its actually quite cool because its such a different mode of exploration, so its like in the lab youre doing one type of hands-on work and then in the classroom youre doing potentially computational work or youre doing more formal studying, test-taking, etc., and then in a theater context youre on your feet and youre thinking on a completely different axis, and so its kind of nice because then your hobby is legitimately relaxing, (laughs) so its I think it provides a kind of built-in break, so it becomes quite manageable.

CS:Nice. So youve taken a ton of classes at this point. What have been some of your favorites?

NO:Oh, man. So I took a few classes with Professor Bob Sandberg in the English department, which were really, really great. I think they changed how I think about theater a lot and how I think about how storytelling works and what it does for people. I think I I also took a philosophy class called Death,(laughs) which was really interesting. I was taking that during the start of the pandemic, which made for a bizarre relevance (laughs) that I didnt anticipate beforehand, but it, I think, shaped some of my more existential positions at this point.

And then, I think, the other one that I would say is Ive taken a couple of quantitative biology classes that have been super important to me, so one of them is Professor Corina Tarnitas class in the EEB department, and then another one is Ned Wingreens graduate seminar in quantitative biology, and I think I mean, I like math, and Ive liked math for a long time, but I think I didnt really see the overlap between that interest and my very experimental approach to life sciences that I generally take, and so its been really cool to learn about how to apply quantitative tools to answer questions that you cant really answer by experimental means, like questions about how things evolved, for instance, which theres not really a different angle that you can take, and its really cool to see that even with my, I think, comparatively more limited math background, there are lots of cool quantitative avenues towards science that I can take.

CS:Nice. So, you mentioned the pandemic. I was going to ask you about that. Obviously, its been a major part of your college journey. Can you talk about how the pandemic has impacted you personally, and if theres ways that its shifted your perspective and outlook on maybe both what it means to be a student and your career moving forward?

NO:Yeah. I mean, I think a couple of things, but then the first thing is that I think every Princeton student had a different pandemic Princeton experience, and I was really lucky in that I went home to a safe learning environment. And I know that wasnt true for a lot of students, so I think thats worth acknowledging. So I think personally, it was obviously very disappointing to not be able to interact with people and to not be able to do hands-on research for a long time and especially to not be able to do in-person theater performances because Zoom theater really doesnt cut it for me. (laughs)

But I think, all in all, I was really lucky. But I think, more broadly, its I think people have been talking a lot more about what kind of public relationships to science are, so Ive been thinking more about issues of science communication and how I want that to be a part of my future career in science education because I think its increasingly apparent that there is a need to speak responsibly about science and to educate people about science so that the world as a whole can respond to global challenges in an appropriate way.

CS:Following that line of thinking, ultimately, what would you say would be your dream job then?

NO:Oh, man. I think so, tentatively speaking, I think I would like to go into academia because I like both research and teaching a lot, and I want both of those things to be part of my life in some capacity, and even if I dont go into academia, I think informally, at least, I want both mentorship and research to be part of my future career. But thats all Ive got worked out at this stage.

CS:Its totally fine. Theres still tons of time to decide and figure out what you want to do. Switching gears a little bit to the upcoming Commencement, have you given your thought some your speech some thought? Have you written it? Its OK if you havent.

NO:Yeah. Im taking the time-honored Princeton approach of writing it at the last minute, I think.

CS:Are there any themes or messages that youve you really hope to impart on your classmates and how you want to leave them with?

NO:This is very tentative. It might not make it in, but I think some of what Im thinking about right now is that, I think, its an interesting moment to be thinking about transition and to be celebrating transition because I think theres a lot of things that are happening in the world that are really terrible for a lot of people, and things for a long time have been unpleasant for pandemic reasons and social inequality reasons and global turmoil reasons, and so I think that kind of changes the valence of what I think a graduation experience feels like in the moment. And so, I want to be cognizant of that, and I want to acknowledge that, but I dont quite know how yet.

And I think the other thing is that, I think if I could impart anything, I think it would be some kind of wish that people take care of themselves and each other, and I havent thought of a great articulation for that yet, but thats where Im thinking.

CS:Those are good messages.

NO:Thank you.

CS:I wanted to also ask you about your thesis. Can you talk about where the idea came from, and what its been like working on it for a while now?

NO:Yeah, for sure. In my thesis, Im looking at how these two proteins contribute to how squishy the nucleus is, the idea being that the squishier the cell nucleus, the better the cell is at climbing through little spaces and maybe at metastasizing, if its in a cancer context. And, so Cliffs lab generally works on these physical approaches to biology, and so this is, I think, not one of the main focuses of the lab at this point, but that kind of mechanical thinking is very much a part of how he approaches biology, and so I think thats where a lot of it comes from. And for me personally, I think theres just a lot of appeal in being able to take a tiny, microscopic thing and then poke it and see how it changes shape. And Im a massive microscopy nerd, so its been a lot of fun to both learn the relevant techniques to actually do the experiments and to conceptualize the project as a whole.

CS:Nice. So reflecting on the entirety of your journey as a Princeton student, what has been some of the most challenging parts?

NO:For me definitely managing mental health has been a challenge. I think even more so because of the pandemic because youre automatically also isolated from other students and from University resources. So I think a lot of it for me has been learning to manage anxiety and patterns of thinking under intense stress, because I think the Princeton semester is really fast, often painfully so.

And then I think also learning to juggle academic rigor and social health. I think especially during my first two years at Princeton, I was very much locked in a library until two in the morning, that kind of thing, and then I think the pandemic shifted a lot for me in terms of what I prioritize because I think now I spend more time with friends and I try to seek out the people I care about and make sure that theyre doing OK and in the process make sure that Im doing OK, which sometimes it feels like thats not what Princeton is built for. It feels a little bit like the expectation is that school is the first thing that you do and maybe also the last thing that you do, and if youre able to squeeze in a little bit of socializing, then good on you, but I think Ive struggled with that a bit, but Ive come to a better balance now.

CS:Thats good. You mentioned social life. What do you do outside of academics, and what do you do for fun?

NO:I play a lot of board games lately. Thats been whats been happening.

CS:Are you on the Wordle trend?

NO:I am. My friends and I all do it together, which I think is an exceptionally nerdy thing. My partners really into board games, so is our broader friend group, so thats become my go-to social activity.

CS:Favorite board game?

NO:Race for the Galaxy. Its a sci-fi themed card game, essentially.

CS:Awesome. So, you reflected on your own journey, but Im curious what advice you would offer to the incoming class if you could talk to them and just share some tidbits and tips from your journey.

NO:Sure. I think my main thought is that there is no wrong way to do Princeton. I think you come in with the sense that theres this particular arc that is prescribed and that it culminates in thesis work, and thesis work must be massively rewarding in order for you have done Princeton correctly, and the priority has to be this but then you also have to be in 70 million extracurriculars, and I think that thats ridiculous and most people dont actually live like that. I think I dont know anyone who actually lives like that. But coming to that conclusion is hard and is a process, and I think everyone goes through that process. And so I just I hope that incoming students can increasingly feel like theyre doing Princeton correctly, regardless of how theyre doing Princeton.

And also I think I would tell people that this place is hard, and it is OK to be finding it hard, and it is OK to be finding it hard in terms of academics and in terms of social things and in terms of extracurricular things because I think everyone struggles with different stuff.

CS:Absolutely. Great advice. You talked about your dream job. We wont hold it in stone. Its OK if you change your mind, but can you talk about what we can expect to see from you next; what are your plans after Princeton, after graduation; and if you have any other goals youd like to share?

NO:Yeah, sure. So, Im starting a Ph.D. program in the fall, because clearly I didnt get enough of school yet, but yes, Im starting a biological and biomedical sciences program at Harvard, and Im really excited to get to do research full time. I think Ive been pretending to be a grad student for a while, and Ive generally really enjoyed that mode of existence, so I think Im excited to keep doing basic biology research and then really excited to keep growing as an educator in particular, so, those are after taking the summer off because I think a break would be nice.

CS:Are you planning to do anything fun with your break?

NO:Yeah, Im planning to do nothing for much of it, which I think

CS:That sounds lovely.

NO: is a top priority right now, but spending time with family mainly.

CS:Absolutely. Great. Well, Natalia, its been wonderful speaking with you and getting to know you. Thanks again for coming on the PAWcast and best of luck.

NO:Yeah, thank you so much.

PAWcast is a monthly interview podcast produced by the Princeton Alumni Weekly. If you enjoyed this episode, please subscribe. You can find us on Apple Podcasts, Google Podcasts, Spotify, and SoundCloud. You can read transcripts of every episode on our website,paw.princeton.edu. Music for this podcast is licensed from Universal Production Music.

Follow this link:
PAWcast: Valedictorian Natalia Orlovsky '22 on Research, Mental Health, and Pandemic Princeton - Princeton Alumni Weekly

Posted in Pennsylvania Stem Cells | Comments Off on PAWcast: Valedictorian Natalia Orlovsky ’22 on Research, Mental Health, and Pandemic Princeton – Princeton Alumni Weekly

‘World’s Greatest Tuba-Playing Car Salesman’ Bounces Back after Leukemia, Thanks to Wilmot Team – URMC

Posted: July 3, 2022 at 2:32 am

Returning home after a Fathers Day trip to New York City with his daughter in 2016, Scott Kesel thought he had come down with the flu. Bloodwork showed his blood platelets were lower than normal. He followed up with his regular physician and was given the news: he had chronic myelomonocytic leukemia (CMML).

CMML is a rare type of blood cancer that starts in the bone marrow, where blood cells are made. It can involve other areas of the body. There are only about 1,100 cases in the U.S. each year and its more common in people over age 60.

As a Canandaigua resident, Scott started his cancer journey at Wilmot Cancer Institutes Sands Cancer Center at F.F. Thompson. His oncologist laid out all the options: chemo and a stem cell transplant.

Knowing he would need a transplant, his team at Sands had him transfer to Wilmots Hematology team, where he began seeing Jason Mendler, M.D., and his transplant doctor, Omar Aljitawi, M.B.B.S.

He had chemotherapy at Wilmot, where he got to know the infusion nursing staff.

They have put a mindset in place thats so beneficial to the patient, he says.

For a stem cell transplant, his brother was the closest match they could find, although he was only a half-match. That left the option for a haplo-identical transplant available. Historically, it was required to have a closer match in order to do a transplant. With a haploidentical transplant, the donor is only half-matched. Its a newer procedure that is not available at all transplant centers, but the doctors at Wilmot have been performing the surgery since 2015.

He underwent the transplant but, unfortunately, in Scotts case, it didnt work.

For a short period, Scott went to another institution for a clinical trial. Unfortunately, that didnt work either. He developed pancreatitis and had to drop out of the trial. He also experienced cold agglutinin disease, which caused his immune system to attack his red blood cells. Cold temperatures can trigger it and he had to stay at Wilmot for about a month in a temperature-controlled room, set at 80 degrees at all times, to overcome it.

Once that resolved, the team at Wilmot suggested another treatment option to try on Scotts leukemia: a transplant with stem cells from an umbilical cord donation. Umbilical cord blood stem cells came from Australia and Spain to try to save Scotts life. He had only two cord blood units available and he needed both to have a successful transplant, which was his only viable chance to potentially cure his leukemia. Along with the cord blood, he also had radiation therapy with Louis Constine, M.D.

He had nothing but good things to say about the team that took care of him while he was hospitalized on Wilmot Cancer Centers sixth floor, the Blood and Marrow Transplant Unit.

It was exceptional. They were so friendly and accommodating right from the very beginning, he says. It wasnt limited to nurses. Theres medical technicians on the floor that were so friendly and became very good friends.

Scott Kesel (right) with Jason Mendler, M.D., at the 2019 Wilmot Warrior Walk

Thankfully, this time the transplant took. As of June 2022, Scott has been in remission for three-and-a-half years. He credits his team for getting him there.

Its an incredible group of people, he says.

But its not just his team hes grateful for. He appreciates that his life has returned basically back to normal, despite the tumultuous COVID pandemic that happened shortly after his transplant.

Hes gotten back to work and to hobbies he enjoys outside work.

I happen to be the worlds greatest tuba playing car salesman, he jokes.

This summer and fall, he has 28 gigs lined up, with different music groups around the region to keep him busy, and he looks forward to hunting and fishing during his free time.

For it all, he feels fortunate.

You have to be grateful for the outcome, he says. I got a lot of support remotely from people in my community who used the opportunity to promote bone marrow registration and blood drives, which was awful nice.

He adds, Im grateful that I ended up at Wilmot. I really couldnt have been in a better place.

See the original post:
'World's Greatest Tuba-Playing Car Salesman' Bounces Back after Leukemia, Thanks to Wilmot Team - URMC

Posted in New York Stem Cells | Comments Off on ‘World’s Greatest Tuba-Playing Car Salesman’ Bounces Back after Leukemia, Thanks to Wilmot Team – URMC

Hadjiargyrou Is New York Tech’s First Distinguished Professor | Box | New York Tech – New York Institute of Technology

Posted: July 3, 2022 at 2:32 am

Professor Michael Hadjiargyrou, Ph.D., chair of the Department of Biological and Chemical Sciences and director of the D.O./Ph.D. program, has been named New York Institute of Technologys first distinguished professor. This designation is found at most top research universities and recognizes outstanding faculty who have achieved the highest levels of scholarship over the course of their careers, earning national- and international-level distinctions and honors of the highest caliber.

Interim Provost Jerry Balentine, D.O., and I were 100 percent in agreement that Professor Hadjiargyrou should be the first at New York Tech to receive this designation, notes New York Tech President Hank Foley, Ph.D. We have some very impressive faculty researchers, and he is absolutely one of the best. He is instilling his passion for research in our students while conducting important work in our labs in a variety of areas.

Foley pointed to the range of Hadjiargyrous work, which includes studying polymeric electrospun nanofibers for cell/gene/drug delivery systems, gene and miRNA (microRNA) expression, stem cells, and the molecular and cellular basis for bone development and regeneration, and the exciting implications his research has for future applications, such as gene delivery and treatment of difficult fractures.

According to his Google Scholar profile, Hadjiargyrou has an h-index (a measure research impact based on the total number of his publications and citations) of 37, one of the highest of any New York Tech researcher and considered to be outstanding in the greater research community. Between 1998 and 2022, his published research has been cited 7,711 times. In addition to his scientific research, Hadjiargyrou has also published thought leadership and opinion pieces on topics ranging from scientific integrity to teaching practices.

I am humbled by being named distinguished professor, and I will continue to live up to the title, says Hadjiargyrou. I would like to deeply thank President Foley and Interim Provost Balentine, not only for bestowing this award, but more importantly, for their continual support of my research activities.

Hadjiargyrou, who joined New York Tech in 2012, has been responsible for reinvigorating the Department of Biological and Chemical Sciences, including enriching the curriculum and support for research activities; hiring talented, engaged faculty researchers; and establishing the D.O./Ph.D. program in medical and biological sciences. During his tenure, he has worked to expand the number of undergraduate research opportunities, which has become the hallmark of a New York Tech education.

The creation of a distinguished professorship at New York Tech supports our goals of becoming a [Carnegie-classified] Research 2 university within the next seven years, says Foley, pointing to the universitys other investments in research activities, including adding new instrumentation and resources, new graduate programs, and hiring new research faculty.

Every two to three years, the distinguished professorship role and criteria will be reviewed by the president and provost, and new candidates will be considered for the designation.

Read the original:
Hadjiargyrou Is New York Tech's First Distinguished Professor | Box | New York Tech - New York Institute of Technology

Posted in New York Stem Cells | Comments Off on Hadjiargyrou Is New York Tech’s First Distinguished Professor | Box | New York Tech – New York Institute of Technology

The global tissue engineering market is anticipated to reach US$ 13,236.87 million in 2022 and is project – Benzinga

Posted: July 3, 2022 at 2:32 am

New York, July 01, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Tissue Engineering Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Material Type and Application" - https://www.reportlinker.com/p06289941/?utm_source=GNW However, the market is likely to get impacted by the high cost of treatments related to tissue engineering during the forecast period.

Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, material methods, and appropriate biochemical and physicochemical factors to regenerate, preserve, enhance, or replace various types of biological tissues. Tissue Engineering (TE) is a rapidly evolving discipline that aims to repair, replace, or regenerate tissues or organs by converting fundamental physics, chemistry, and biology knowledge into practical and effective materials or devices and clinical strategies.Tissue engineering has several primary functions in medicine and research: Assisting in tissue or organ repair, including bone repair (calcified tissue), cartilage tissue, heart tissue, pancreatic tissue, and vascular tissue.The field also researches the behavior of stem cells.

Stem cells can develop into many different cell types and help repair areas of the body.The 3D nature of tissue engineering allows the study of tumor architecture in a more detailed environment.

Tissue engineering also provides an environment to test potential new drugs for these diseases.The growth in the number of R&D activities with increasing awareness of tissue engineering in emerging markets is expected to support the global tissue engineering market growth.

Developed nations have adopted technological advances in tissue engineering and regenerative medicine that contribute to expanding the global tissue engineering market.Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus.The COVID-19 pandemic has become the most significant challenge across the world.

This challenge was frightening, especially in developing countries worldwide, as it expected to reduce imports due to disruptions in global trade in the coming years.To date, no definitive treatment against the COVID 19 has been established.

Hence, the lack of definitive therapy offers significant opportunities for the tissue engineering market as the US FDA has recently approved the use of plasma therapy for critically ill COVID 19 patients.

Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system in managing the outbreak.The supply chain disruptions and the enormous demand for effective diagnostics and therapeutics for the treatment of COVID 19 put the healthcare research industry in a critical situation in various regions.

Risks were majorly on emerging markets that face healthcare constraints and tighter financial conditions. The COVID-19 pandemic also hampered clinical trials, drug development, and the diagnostics industry's operation in the region.Also, significant disruptions to routine research activities involving tissue engineering and regenerative medicines were observed due to the pandemic.Many industries were affected by the crisis, including tissue engineering research activities, due to the shutdown of research centers, lack of healthcare facilities, and an increasing number of cases.

However, after the emergence of the COVID-19 vaccine, research centers have commenced studies and research on stem cells, regenerative medicine, and other therapies. Hence, the tissue engineering market in Europe is gaining attention after the COVID-19 impact.Based on material type, the global tissue engineering market is segmented into synthetic material, biologically derived materials, and others.In 2022, the biologically derived materials segment is anticipated to account for the highest share of the global tissue engineering market.

A biomaterial plays a significant role in the development of tissue engineering and biomedical devices that naturally increase the regenerative potential of tissues to restore body mechanisms in a state of deterioration.Biologically derived materials are used in creating neo-tissues in vitro that are identical to their fundamental body parts.These materials also help in tissue regeneration by a controlled presentation and on-demand release of specific chemokines at injury sites, tissue-resembling structural, temporary biodegradable support matrices with natural and functional characteristics.

However, the synthetic material segment is likely to register the highest CAGR in the global tissue engineering market during the forecast period.Based on application, the global tissue engineering market is segmented into orthopedic, musculoskeletal & spine, neurology, cardiology and vascular, skin & integumentary, urology, GI & gynecology, cancer, and others.The orthopedic, musculoskeletal & spine segment is expected to lead the market in 2022.

However, the skin & integumentary segment is anticipated to register the highest CAGR in the global tissue engineering market during the forecast period.The World Health Organization (WHO), the US Food and Drug Administration (FDA), Centers For Disease Control And Prevention, American Heart Association, Biomedical Advanced Research and Development Authority, and Foundation For Innovative New Diagnostics are some of the major primary and secondary sources referred for preparing this report.Read the full report: https://www.reportlinker.com/p06289941/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read more here:
The global tissue engineering market is anticipated to reach US$ 13,236.87 million in 2022 and is project - Benzinga

Posted in New York Stem Cells | Comments Off on The global tissue engineering market is anticipated to reach US$ 13,236.87 million in 2022 and is project – Benzinga

Family Health Care Atlanta | Primary & Preventative Medicine

Posted: July 3, 2022 at 2:29 am

Family Practice Center, PC, is a comprehensive medical practice where we provide healthcare the way you hoped it could be. Our attentive, patient-focused approach to medicine is the main reason we have become one of the highest-rated primary care practices in the Georgia. We pride ourselves on providing a wide variety of healthcare needs for our patients including top-level care and in-house-diagnostic testing. Led by practice Founder and CEO Dr. James Wheeler, along with a team of doctors. These physicians, as well as a full team of physician assistants, nurse practitioners, medical assistants, and other healthcare professionals, pride themselves on providing the best possible experience for each and every patient we see.

We strive to offer a wide variety of medical treatments and services, including staying up-to-date with the latest health news and trends, in order to best serve our patients and their loved ones. In addition to general family medicine, our physicians specialize in providing dermatological care, sports medicine, womens health service, and preventative medicine (including immunizations). Our selection of in-house diagnostic testing includes x-rays, bloodwork, ultrasounds, echocardiograms, and more. We are able to perform minor surgical procedures in our office at the convenience of our patients.

Our healthcare providers consider it an honor to take care of our patients and their families. Contact Family Practice Center today for more information or to schedule an appointment. Ask us about Medicare eligibility. And keep an eye out for news about our new locations in the metro Atlanta area.

Excerpt from:
Family Health Care Atlanta | Primary & Preventative Medicine

Posted in Preventative Medicine | Comments Off on Family Health Care Atlanta | Primary & Preventative Medicine

Preventative medicine in Rochester Hills MI

Posted: July 3, 2022 at 2:29 am

Preventative medicine in Rochester Hills MI

Phone & Video Consultations Available - 248-289-6643

Rochester:248-289-6643

Bingham Farms:248-548-3060

Improve the Quality of Life for All

We are on the threshold of a new paradigm; for the first time in history we can apply advanced technologies for early detection, prevention and even reversal of disease

This is evidence-based medicine!It is no myth! -Dr. Lewerenz

Patient Case Assessment & Evaluation Using Functional Medicine

Hormone Replacement Therapy and Functional Medicine Philosophy

2 yearsago

Rest assured! At Longevity Health Institute we are taking every precaution possible regarding the Coronavirus. Our highest priority is the safety and health of you, your family, our staff, and our doctors.Our office has been practicing the highest level of cleanliness, sanitation, and sterilization since...

3 yearsago

Founder of the Longevity Health Institute and Lewerenz Medical Center, Dr. James Lewerenz has been named one of Detroits Top Docs of 2019 by Hour Detroit Media, publisher of Hour Detroit magazine. This honor is exclusive to the area, and top docs are nominated by...

3 yearsago

The male hormone, Testosterone (considering only men) typically lowers with aging. Typical declines are about 1-3 percent a year starting at age 35 to 40. Sometimes even greater. It is not uncommon for me to see a man age 45 with a Testosterone level of...

- Mary C

- Michael L

- Regina G

- Susan F

- Jennifer R

- Vincent S

- James C

- Jason H

- Anon

- Terry T

- Anon

- Lawrence C

- David F

- Heather S

- Rhonda P

- Lisa S

- Luana C

- Anon

- Allison R

- Kathleen W

- Lawrence C

- Mary R

- Margaret F

- Gregory J

- Christine F

- Anon

Dr. Lewerenz named Top Doc by Hour Detroit Magazine

3 yearsago

A study from a European Journal of Clinical Nutrition in 2017 showed that Vitamin C supplementation can improve glycemic (sugar) and insulin regulation. This was a high-quality randomized control trial of the effects of Vitamin C on Glucose, HGBA1C and Insulin.Not only did Vitamin C...

3 yearsago

Consider this: The average American eats 295mg of Cholesterol and 3-4 eggs per week.A new Observational study in JAMA by Dr. Zhongs from the American Medical Association, examined Cholesterol consumed and eggs consumed, both respectively for 17.5 years from a group of 29,615 adults for...

3 yearsago

Who wouldnt want improved sleep, reduced stress, less pain and cramps, improved mood, improved heart, bone and muscle health?Well, that can be achieved by obtaining optimal levels of Magnesium in your body. Magnesium is a critical mineral that the body uses in more than 300...

3 yearsago

CBD or therapeutic hemp oil (cannabidiol) is experiencing a huge growth in the medical world.There is medicinal value and massive public demand in the wellness, holistic and alternative therapy world. There are vast medicinal benefits but what is hype, what is harm and what has...

Site contents 2022 Longevity Health Institute

See the article here:
Preventative medicine in Rochester Hills MI

Posted in Preventative Medicine | Comments Off on Preventative medicine in Rochester Hills MI

Cloning and Stem Cells | Biological Principles

Posted: July 3, 2022 at 2:26 am

Learning Objectives

Gene therapy works best by genetically repairing a patients stem cells. The easiest source of stem cells are from early embryos. The intersection of stem cell technology, genetic engineering, and cloning poses both scientific and ethical challenges.

Many organisms, such as bacteria and archaea, and diverse eukaryotes, reproduce asexually. Asexual reproduction results in progeny that are genetically identical to the parent, meaning that they are clones of the parent.

Most complex, multicellular eukaryotes, however, reproduce only sexually. Two haploid gametes unite to form a diploid cell, called a zygote, that reproduces mitotically to form all the somatic cells of a complex multicellular organism. During mitotic cell divisions, various cells express different sets of genes to differentiate into different organs, tissues, and cell types. Two fundamental questions of biology are: 1) how genes regulate the process of development, and 2) whether somatic cells undergo irreversible genetic changes as they differentiate.

Early experiments with cloning plants showed that individual somatic cells (cells that do not form pollen or egg) could form complete, new clonal plants, indicating that the somatic cells had no irreversible changes in their genome compared to the original fertilized egg cell.

The first studies to test whether vertebrate animals could be cloned used a technique called somatic cell nuclear transfer (SCNT), where nuclei from somatic cells were transferred to an egg cell whose own nucleus had been removed.

Somatic cell nuclear transfer, from Wikipedia. Transfer of a nucleus from a differentiated somatic cell into an enucleated egg cell creates a one-cell embryo that is genetically identical to the donor of the somatic cell nucleus. The embryo is stimulated to divide to form an early-stage embryo consisting of multiple cells (labeled clone in the figure). In reproductive cloning, this early-stage embryo is implanted into the uterus of a surrogate mother. In therapeutic cloning, the early-stage embryo is disaggregated to recover and culture embryonic stem cells. Image source: https://commons.wikimedia.org/wiki/File:Cloning_diagram_english.svg cc-by-sa-3.0

Early studies with enucleated frog eggs found that donor nuclei from early embryos supported development of a complete adult animal, but nuclei from tadpoles or adult frogs could not. These early results suggested that as vertebrate animals progressed through embryonic development, birth, and aging, their somatic cell nuclei became programmed to differentiate into specialized cells, rather than support embryonic development. We now know that this programming involves reversible modification of chromatin that restricts what genes can be expressed in differentiated cells.

The short video below shows the SCNT process:

In 1996, Ian Wilmut and colleagues found that by arresting adult somatic cell cultures in the cell cycle, he could erase some or most of their nuclear programming. Using cultured mammary gland cells from an adult sheep as the source of donor nuclei, he performed 277 SCNTs to create clone embryos. The embryos that divided normally were implanted into the uterus of foster mother sheep. Only a single lamb, Dolly, was successfully born alive and healthy from the 277 attempts. Since then, many other mammalian species have been cloned, with success rates varying from a few to low tens of percent.

https://www.dnalc.org/view/16992-Cloning-101.html

Mammalian reproductive cloning is still inefficient, with a low success rate, complications during pregnancy, and possible premature aging of the cloned offspring (https://learn.genetics.utah.edu/content/tech/cloning/cloningrisks/). As far as we know, no reproductive cloning of humans has yet been attempted.

The human body is quite limited in its ability to regenerate or repair injuries or diseases that affect critical organs such as the brain, heart, and pancreas. Tissue and organ regeneration and gene therapy require a source of cells that can differentiate into the desired types of cells, for the life of the patient. Adult humans have distinct reservoirs of stem cells, located in different parts of the body (such as the bone marrow). Stem cells, by definition, can continue to divide and both replace themselves and produce progeny cells that differentiate into new blood and immune system cells, or skin cells, or cells that line the gut and airways, or muscle cells. But these adult stem cells are difficult to obtain from a patient, and they are restricted in the types of cells or tissues they can form. For example, the stem cells in the bone marrow can generate both white and red blood cells, but not skin cells or new brain cells or heart muscle or pancreatic beta islet cells (to cure diabetes).

Cells in an early human embryo, however, are totipotent or pluripotent they can form any part of the human body. Such cells can be cultured indefinitely as embryonic stem cell lines. Existing human embryonic stem cell lines have been derived from in-vitro fertilized, early-stage human embryos, that would have perished without implantation into a uterus. These were surplus or back-up embryos from fertility clinics, that would have been discarded or put into indefinite cryo-storage.

Therapeutic cloning uses enucleated human eggs and somatic cell nuclear transfer technology to create a human embryo that is a genetic clone of the patient. The embryo is destroyed to obtain embryonic stem cells that have the same genotype as the patient. These cells can be cultured indefinitely, and hormonally induced to form new tissues and organs that will not be rejected by the patients immune system.

Link here to a narrated animation on Human Embryonic Stem Cells (Sumanas Inc)

In the last decade, genetic engineering technology has been used to create a new type of stem cell: induced pluripotent stem cells (iPSCs). These cells, created by transforming adult differentiated cells (such as fibroblasts or skin cells) with 4-6 different transcription factors that regulate early embryonic cell growth and differentiation, have many of the properties of embryonic stem cells. The question is whether these transcription factor genes can be safely used to transform the patients own cells without causing unacceptably high risks of cancer once these cells are reintroduced into the patients body. Because iPSCs do not involve destruction of human embryos, they have been the focus of intense research. A review by Wilson and Wu (2015) provides a concise description of the state of the research and the challenges in this field.

Stem cells, depending on whether they were obtained from adults, embryos, or induced with transcription factors, can be induced to differentiate into different cell types to generate replacement organs and repair damaged heart muscle, pancreatic beta cells, spinal cord or brain cells. Coupled with genome editing, stem cells could be used to treat patients with genetic disorders.

Slides for the videos above:

B1510_module5-2_Cloning_StemCells_2011

Wilson, KD and JC Wu (2015) Induced Pluripotent Stem Cells, JAMA. 313(16):1613-1614. doi:10.1001/jama.2015.1846

https://learn.genetics.utah.edu/content/tech/cloning/whatiscloning/

https://learn.genetics.utah.edu/content/tech/cloning/clickandclone/ go through the steps to clone a mouse using somatic cell nuclear transfer technology

Original post:
Cloning and Stem Cells | Biological Principles

Posted in Utah Stem Cells | Comments Off on Cloning and Stem Cells | Biological Principles

Effect of tensile frequency on osteogenic differentiation | IJGM – Dove Medical Press

Posted: July 3, 2022 at 2:26 am

Introduction

Mechanical stress enhances bone metabolism and periodontal tissue remodeling.1 During orthodontic tooth movement (OTM), bone remodeling is initiated via the periodontal ligament.2 As the main mesenchymal stem cells (MSCs) in the periodontal ligament, periodontal ligament stem cells (PDLSCs) play an important role in mechanical signal transduction. Currently, a consensus has been reached that cyclic mechanical tension is a strong driver of the differentiation of PDLSCs into the osteoblast lineage.24 Mechanical tension activates calcium channels,5 which activate the ERK1/2 and P38 MAPK pathways through integrin-FAK or protein kinase (PKC)-SR signaling6 and induce the phosphorylation of Runt-associated transcription factor 2 (Runx2),7 promoting osteogenic precursor cell synthesis and the transcription of mineralizable proteins.8 At present, the TGF-, BMP, MAPK, Notch, Wnt, Hedgehog, FGF, and Hippo signaling pathways have been found to be involved in this process.

Force parameters (including magnitude, frequency, and duration) are crucial for well-regulated tissue remodeling. However, numerous in vitro studies performed to date show enormous heterogeneity in tensile force parameters.9 In different studies, cyclic tension was applied with magnitudes ranging from 1% to 24%, frequencies ranging from 0.1 Hz to 1.0 Hz, and stimuli duration ranging from 1 hour to 6 days, thereby reducing comparability between different studies.9 To establish strategies to optimize tensile force parameters, it is of particular importance to understand how different tensile force parameters affect the osteogenic differentiation of PDLSCs.

The effects of different tensile force magnitudes and durations have been investigated in some studies. Among the magnitudes, a magnitude of 10% generally led to a lower level of inflammation and a higher level of osteogenesis,10 whereas a magnitude of 12% was found to correlate well with strain conditions at the mid-root under physiological loading conditions11,12 and to induce optimal effects in both the proliferation and osteogenesis of PDLSCs.13 Cyclic tension alone at 3000 strain significantly enhanced SATB Homeobox 2 (Satb2) after 3 h of loading and significantly upregulated Runx2 after 6 h.14 The synthesis of BMP9 increased under 6-h continuously applied cyclic tension.15 In addition, 12% cyclic tensile force gradually upregulated the expression of Runx2, alkaline phosphatase (ALP), and osteocalcin (OCN) with force durations of 6 h, 12 h, and 24 h, respectively.16,17 The protein level of osterix increased stepwise following 3 h, 6 h, 12 h, and 24 h of exposure to tensile strain.14 Recently, temporal gene expression patterns were delineated.17

Tensile frequency varies largely among different studies. The ROCKTAZ pathway and its interaction with Cbf1 were found to be essential for the cyclic tension (12% elongation, 0.1 Hz)-induced osteogenic differentiation in PDLSCs.18 Cyclic tension (10% elongation, 0.5 Hz) stimulated the osteogenic differentiation of PDLSCs by inhibiting miR-129-5p expression and activating the BMP2/Smad pathway.17 LncRNAs-miRNAs-mRNAs networks in PDLSCs were depicted under cyclic tension (10% elongation, 1.0 Hz).19 However, there have been rare studies examining the impact of different cyclic tensile frequencies on osteogenesis of PDLSCs and the expression of relevant genes thus far. The low-magnitude high-frequency (LMHF) vibration approach was excluded because it is used to simulate a masticatory force, while cyclic tension is used to simulate an orthodontic force, and the two methods of force application are completely different.2,20 Previous animal studies on long bone distraction osteogenesis have shown that loading frequency affects the osteogenic response of bone tissue.21 The mechano-regulation of trabecular bone adaptation is logarithmically dependent on the loading frequency.22 Therefore, we hypothesized that tensile frequency would affect osteogenesis of PDLSCs, in which some tensile frequency-sensitive genes may play an important role. To test our hypotheses, human PDLSCs were subjected to cyclic mechanical tension at different frequencies of 0.10.7 Hz to examine the osteoblastic differentiation of PDLSCs, and high-throughput sequencing was performed to characterize the frequency-course expression patterns of mRNA during the osteogenic differentiation of PDLSCs. This study aimed to investigate the effects of tensile frequency on the osteogenic differentiation of PDLSCs as well as the relevant molecular mechanisms.

Healthy periodontal ligament tissues were scraped from the middle third of tooth roots, which were extracted for orthodontic reasons, with informed consents. All donors were aged from 14 to 16 years and had no systemic or oral diseases. The periodontal ligament tissues were cut into small pieces and enzymatically digested for 40 min at 37C with collagenase I (3 mg/mL, Sigma-Aldrich, St. Louis, MO, USA) and dispase II (4 mg/mL; Sigma-Aldrich). The cells were seeded in 25 cm2 flasks (Falcon, BD Biosciences, Franklin Lakes, NJ, USA) with -minimal essential medium (-MEM; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, Gibco, Life Technologies Co., Grand Island, NY, USA) and antibiotics (100 U/mL penicillin and 100 g/mL streptomycin, Hyclone, Logan, Utah, USA), and incubated in a humidified atmosphere (37C, 5% CO2). The medium was changed every 3 days. After reaching 80% of confluence, the cells were detached with 0.25% trypsin/EDTA (Gibco, Life Technologies Co., Grand Island, NY, USA), and single-cell suspensions were cloned with the limiting-dilution method to purify the stem cells.17 Cell clusters from the colony were trypsinized and serially sub-cultured.

The third-passage PDLSCs were sub-cultured into six-well plates until confluent. The culture medium was then removed, and cells were fixed with 4% formaldehyde (Zhonghuihecai, Xian, CN) for 20 min, permeabilized with 0.3% Triton X-100 (Zhonghuihecai) for 5 min, and incubated with primary antibodies (anti-pan-cytokeratin, 1:300, Abcam, Cambridge, MA, USA; anti-vimentin, 1:500, Abcam; anti-STRO-1, 1:200, Abcam; anti-CD146, 1:200, Abcam) overnight at 4C. The cells were then washed with PBS and incubated with CY3/FITC-conjugated secondary antibodies (1:500, Zhuangzhi, Xian, CN) in darkness for 30 min, and then washed with PBS. Finally, the nuclei were counterstained with 4, 6-diamidino-2-phenylindole (DAPI, Zhuangzhi), and fluorescent images were captured with a fluorescence microscope (Olympus, Japan).

For osteogenic and adipogenic differentiation, PDLSCs were seeded into six-well plates at a density of 2105 cells/well, and after reaching 80% confluence, the medium was replaced with an osteogenic or adipogenic inductive medium (Osteogenesis or Adipogenesis Differentiation Kit, Cyagen, USA). Seven days after osteogenic induction, the cells were stained with ALP (ALP staining kit, Solarbio, CN), and 14 days after osteogenic incubation, the cells were stained with Alizarin Red (ARS staining kit, Cyagen, USA). After 21 days of adipogenic incubation, the cells were stained with Oil Red O (Cyagen, USA).

Flexcell FX-5000T Tension Plus System (Flexcell International Corporation, Hillsborough, NC, USA) was used to mimic the tensile force exerted on PDLSCs during OTM, according to previous studies.23 Cyclic tensile loading experiments were performed on the fourth-passage PDLSCs from four different healthy donors in triplicate. PDLSCs were seeded onto six-well type I collagen (COL-I)-coated silicone culture plates (Flexcell International Corporation) at a density of 2105 cells/well. Upon reaching 80% confluence, the cells were serum-starved overnight, and the medium was changed to osteogenic medium (Cyagen, USA). Cyclic tensile force (12% bottom membrane elongation) was applied to different plates at different frequencies of 0.1 Hz, 0.5 Hz, and 0.7 Hz. Control cells were cultured under identical culture condition but without mechanical stimulation.

After 10 h of cyclic tensile force, the cells were collected. Proteins were isolated, electrophoretically separated, and immunoblotted as previously described.23 Briefly, PDLSCs were lysed with RIPA buffer containing 1% phenylmethanesulfonyl fluoride (PMSF, proteinase inhibitor, Zhonghuihecai) and 1% phosphatase inhibitor (Zhonghuihecai). After centrifugation, the supernatant was collected and measured quantitatively using a BCA Protein Assay Kit (Absin, Shanghai, CN). Total protein from cell lysates (20 g/lane) was separated by SDS-PAGE gels (Beyotime, Hangzhou, CN) and then transferred onto a polyvinylidene difluoride (PVDF) membrane (EMD Millipore, Billerica, MA, USA). After blocking with 5% skimmed milk in tris-buffered saline tween-20 (TBST) for 2 h at room temperature, the membranes were incubated overnight at 4C with primary antibodies (runt-related transcription factor 2 (Runx2), 1:500, ImmunoWay, USA; COL-I, 1:1000, Proteintech, USA; Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 1:10000, Proteintech, USA), followed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibody (1:2000, Proteintech, USA) for 2 h at room temperature. The protein expression was visualized using ChemiDocTM XRS+ (Bio-Rad Laboratories, Inc., Hercules, CA, USA) with an enhanced chemiluminescence (ECL) kit (Millipore, Billerica, MA, USA). GAPDH was used as an internal control for normalization.

The fourth-passage PDLSCs from three donors were used for RNA sequencing after tension loading. Total RNA was extracted from the four groups of cells (normal PDLSCs and PDLSCs tensioned at frequencies of 0.1 Hz, 0.5 Hz, and 0.7 Hz for 6 h) using the Trizol (Sigma-Aldrich), according to the manufacturers protocols. After digestion with DNase, rRNA were depleted using a Ribo-Zero magnetic kit, and sequencing libraries were constructed as previously described.24 The sequencing of the cDNA library was carried out by Gene Denovo Biotechnology Co. (Guangzhou, China). The gene expression level was evaluated by reads per kilobase transcriptome per million mapped reads (RPKM). Requirements for filtering differentially expressed genes (DEGs) were as follows: (1) |log2 (fold-change)| 1; (2) p value < 0.05. DESeq2 (differential gene expression analysis based on the negative binomial distribution)25 was used to calculate p values and adjusted p (adj. p) values. Heatmaps and volcano plots analyses were used to visualize these DEGs using the Complex Heatmap package and ggplots2 package of R software. The online tool Venny 2.1 (http://bioinfogp.cnb.csic.es/tools/venny/index.html) was applied to identify the common DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were used for annotation visualization and integrated discovery. Raw data of the performed RNA sequencing (RNA-seq) were recorded in the SRA database with the SRA accession: PRJNA665587.

Gene expression pattern analysis is used to cluster genes of similar expression patterns for multiple samples in a tensile frequency order. To examine the expression pattern of DEGs in different frequencies, the expression data of each sample (in the order of treatment) were normalized to 0, log2 (v1/v0), and log2 (v2/v0), and then clustered using the Short Time-series Expression Miner software (STEM).26 The parameters were set as follows: (1) maximum unit change in model profiles between frequency points was 1; (2) maximum output profiles number was 20 (similar profiles will be merged; and (3) minimum ratio of fold change of DEGs was no less than 2.0. The clustered profiles with p value < 0.05 were considered as significant profiles. Then, the DEGs in all profiles or in each profile were subjected to GO and KEGG pathway enrichment analysis. STRING (https://string-db.org/) was used for PPI network analysis. The DEGs were mapped onto the PPI network with a minimum interaction score of 0.4. Cytoscape v3.7.1 software was used to visualize the PPI network. Gene network clustering analysis was performed to identify the key PPI network modules, using the MCODE and cytoHuba app from the Cytoscape software suite. Adj. p value < 0.05 was set as the significance threshold.

Total RNA was extracted using Trizol (Sigma-Aldrich) according to the manufacturers protocols. Quantitative real-time PCR (RTqPCR) was performed in triplicate using the Power SYBR Green PCR Mastermix (Applied Biosystems, Foster City, CA, USA). Sequences of the primers used are shown in Table S1. The mean expression values were calculated relative to GAPDH, which was used as an internal control for normalization.

For differential gene expression analysis, a likelihood ratio test was used assuming an underlying zero-inflated negative binomial distribution.25,27 FDR-corrected p-values were calculated using the Benjamini-Hochberg procedure.28 K-means cluster method29 was used for frequency cluster expression pattern analysis by the STEM software. P and Q values of GO/KEGG functional analysis and frequency cluster analysis were calculated based on a hypergeometric distribution.30 Values of the relative protein and mRNA expression were expressed as mean SD within each group. One-way ANOVA followed by SNK post hoc tests was used in the Western blotting assay and RTqPCR assay. The significance threshold was set at 0.05.

Immunofluorescent staining revealed that the isolated cells were positive for CD146, vimentin, and STRO-1 (Figure 1AC, respectively) but negative for pan-cytokeratin (Figure 1D), confirming that the cells were mesenchymal stem cells of mesodermal origin. The osteogenic potential of PDLSCs was determined by positive ALP staining after 7 days of osteogenic induction (Figure 1E and F) and red mineralized matrix nodules in Alizarin Red staining after 14 days of osteogenic induction (Figure 1G and H). The presence of red lipid droplets in Oil Red staining after 21 days of adipogenic induction (Figure 1I) indicated the adipogenic differentiation of PDLSCs.

Figure 1 Identification of PDLSCs. The Immunofluorescence showed that the cells were positive for CD146 (A, red), vimentin (B, green), and STRO-1 (C, red) but negative for pan-cytokeratin (D). Scale bar = 50 m. ALP staining was positive both visually (E, black) and under the microscope (F, black, Scale bar = 100 m), after 7 days of osteogenesis induction culture. After 14 days of osteogenesis induction, ARS staining was observed to be positive by the naked eye (G, red), and mineralized nodules were obvious under the microscope (H, red, Scale bar = 100 m). After 21 days of adipogenic induction, oil red O-positive lipid clusters were observed microscopically (I, red, Scale bar = 100 m).

PDLSCs were exposed to 12% cyclic tension, which contributed to the cellular reorientation, including an irregular arrangement at the central region and a parallel arrangement at the peripheral region of the plate (Figure 2A). As shown in Figure 2B and C, after consecutive 10-h cyclic tensile force loading, the protein expression levels of Runx2 and COLI increased with increasing tensile frequency from 0.1 Hz to 0.7 Hz and were remarkably higher than that in the group without tension application (p < 0.05). The result suggested that mechanical tension (12% deformation) upregulated the osteogenesis of PDLSCs in a frequency-dependent manner. Higher frequencies of cyclic tension were associated with higher osteogenic differentiation of PDLSCs.

Figure 2 Cyclic tension promoted the osteogenic differentiation of PDLSCs. Under cyclic equibiaxial tension, PDLSCs reoriented in parallel alignment at the peripheral region of the plate, while in random orientation at the center of the plate (A, Scale bar = 100 m). Western blotting was used to detect protein levels of osteogenesis-related genes, COL-I and Runx2, at different tensile frequencies (B and C). **p < 0.01, ***p < 0.001, vs control group.

It has been previously shown that cyclic mechanical tensile stress can improve osteogenesis of PDLSCs, and that consecutive 46 h of tension can significantly upregulate the mRNA expression of osteogenesis-related genes.16,17 To gain insight into the molecular mechanisms by which mechanical tension stimulates osteoblast differentiation of PDLSCs, total RNA was extracted from PDLSCs to conduct RNA-seq after 6 h of cyclic tension. The mRNA expression profiles of the PDLSCs at different tensile frequencies (0.1 Hz, 0.5 Hz, and 0.7 Hz) were detected. Comparative expression analyses were performed according to the different frequencies of the tensile stress (0.1 Hz vs control, 0.5 Hz vs control, and 0.7 Hz vs control). Heat maps of the top 40 DEGs (Figure 3AC) and volcano plots (Figure 3DF) were depicted. In total, 50 mRNAs were upregulated, and 261 mRNAs were downregulated at 0.1 Hz. At 0.5 Hz, 656 mRNAs were upregulated, and 1474 mRNAs were downregulated. At 0.7Hz, 139 mRNAs were upregulated, and 194 mRNAs were downregulated. A Venny analysis (Figure 3G and H) showed that 78 genes were simultaneously upregulated and 118 were simultaneously downregulated among the 0.1 Hz, 0.5 Hz, and 0.7 Hz groups. The GO analysis (Figure 4A) demonstrated that changes in biological processes (BPs) were mainly enriched in metabolic process, response to stimulus, biological regulation, signaling, and localization. Changes in Cellular Components (CCs) were mainly enriched in organelle, membrane, macromolecular complex, and membrane-enclosed lumen. Moreover, binding, catalytic activity, and nucleic acid binding transcription factor activity emerged as the highest-ranked Molecular Function (MF) groups. As shown in Figure 4B, DNA replication, cell cycle, and the TNF signaling pathway were significantly enriched in the KEGG pathway. Within the primary category Environmental Information Processing, Signal transduction, and Signaling molecules and interaction were strongly enriched (Figure 4C).

Figure 3 Identification of DEGs among different frequencies. (AC) Heatmaps of the top 40 DEGs between 0.1 Hz/0.5 Hz/0.7 Hz and static culture, respectively. Red rectangles represent high expression, and blue rectangles represent low expression. (DF) Volcano plot of DEGs between 0.1 Hz/0.5 Hz/0.7 Hz and static culture, respectively. The red plots represent upregulated genes, the blue plots represent downregulated genes, and the black plots represent nonsignificant genes. (G) Venn diagram of upregulated DEGs among 0.1 Hz, 0.5 Hz, and 0.7 Hz. (H) Venn diagram of downregulated DEGs among all the three frequencies.

Figure 4 Functional enrichment analysis of all DEGs. (A) GO enrichment analysis of all DEGs among different frequencies. (B) Top 20 pathways of the KEGG enrichment analysis of all DEGs among different frequencies, with the KEGG pathway annotation (C). The screening criteria for significance were p value < 0.05.

The sequencing data were normalized to the control, and trend analyses of DEGs were identified using STEM. In Figure 5A, within the 20 model profiles, eight mRNA trend profiles were statistically significant. The profile number assigned by STEM was on the top left corner of each profile box, p value was on the bottom left, and the number of the cardinality of each cluster was on the top right corner. As shown in Table 1, among different profiles, the top-ranked KEGG pathways were mainly in the metabolic pathways, PI3K-Akt signaling pathway, cytokine-cytokine receptor interaction, and MAPK signaling pathway. A continuous downregulation pattern was found in profile 0 (Figure 5B), in which the high-ranked BPs, CCs, and MFs in GO enrichment (Figure 5C) were similar to those in Figure 4A, and inflammatory pathways such as arachidonic acid metabolism, peroxisome, and cytokinecytokine receptor interaction were strongly enriched (Figure 5D).

Table 1 Top 10 of KEGG Enrichment Among Different Profiles

Figure 5 Frequency series clustering analysis on expression profiles of mRNAs by STEM. (A) Within the 20 model profiles, eight mRNA trend profiles were statistically significant. The number at the upper-left corner of each profile box was the profile number assigned by STEM, the number on the bottom left was the p value, and the number on the top-right corner was the number of genes within each cluster. (B) Persistently downregulated genes along frequency were clustered in profile 0. (C) GO enrichment of profile 0. (D) Top 10 pathways of the KEGG enrichment of profile 0.

The interactions of 194 DEGs in profile 0 were analyzed using the STRING online database, and the PPI network was obtained using the Cytoscape software (Figure 6A). The MCODE plugin was then used to investigate the key PPI network modules, and one key module with four genes (EYA1, SIX5, SALL1, FRAS1) was identified (Figure 6B). The cytoHubba plugin was then used to analyze hub genes with maximum correlation criterion (MCC)/Degree, and genes with the top 10 scores were respectively identified. The intersection (EYA1, SALL1) of hub genes according to the above three methods were selected for further RTqPCR validation (Figure 6C). The results of RTqPCR (Figure 6D and E) showed that the mRNA expression of EYA1 and SALL1 decreased with increasing frequency from 0.1 Hz to 0.7 Hz, which were highly consistent with our high-throughput sequencing.

Figure 6 Identification and validation of mechanofreqency-sensitive hub genes. (A) The interaction network between proteins coded by the DEGs in profile 0. The nodes represent genes, and the edges represent links between genes. Blue represents downregulated genes. (B) The highest scoring module was extracted by MCODE. (C) The intersection was obtained among modules measured by MCODE, and the top 10 highly connected genes were identified using MCC and Degree in cytoHubba. (D and E) Validation of the expression of the two intersection genes, EYA1 and SALL1, using RTqPCR. *p < 0.05, vs control group.

OTM is based on remodeling processes in the periodontal ligament and the alveolar bone. PDLSCs play an important role in mechano-transduction and in promoting periodontal tissue regeneration in OTM.31,32 It is evident that cyclic tensile force regulates the osteogenic differentiation of PDLSCs.33 A complex network of signaling molecules regulates the osteoblastic differentiation of PDLSCs under cyclic tension.5,17,34 The heterogeneity of mechanical force parameters (duration, magnitude, frequency, and others)9 led to the heterogeneity of the osteogenic phenotype and gene regulation in different studies. This study focused on the effect of tensile frequency on the osteogenic differentiation of PDLSCs and attempted to elucidate a potential mechanism.

In the current study, we successfully isolated and characterized human PDSLCs. The cells at the 4th to 6th passage were used, whose phenotype was generally believed to be maintained.35 Mechanical tension was applied using the Flexcell tension system, which has been widely used in PDLSCs studies.2,20 We observed that the cellar reorientation after force loading was similar to that of the previous study,23 and this could be attributed to the mechano-responsive stress fibersfocal adhesion system.36 The present study showed that cyclic mechanical tension (magnitude: 12% deformation, duration: 10 h) in the range of 0.10.7 Hz promoted osteogenic marker genes including Runx2 and COL-I in PDLSCs, and their protein expressions increased with the increasing tensile frequency. Runx2 is an osteogenic lineage commitment specific transcription factor, which binds to the specific cis-acting elements of osteoblasts to promote the transcription and translation of OCN, osteopontin (OPN), bone sialoprotein (BSP), and COL-I.8 COL-I, which acts as a template onto which minerals are deposited to form bone matrix,37 is the major constituent of extracellular matrix in the periodontal ligament and bone, and is confirmed to be essential for osteogenesis in response to tension during OTM.38 Consistently, upregulation of RUNX2 and COL-I in response to tension was reported in most studies.9 To the best of our knowledge, the present study is the first to reveal the frequency dependence during cyclic tension in enhancing the expression of osteogenic markers within the first 10 h of cyclic tension application, which may inform a new method of accelerating OTM.

Using RNA-seq, we observed that mRNAs in strained PDLSCs were mainly enriched in response to the stimulus process, signal transduction, and relative pathways such as mismatch repair, TNF signaling pathway, and FOXO signaling pathway, which were associated with cell survival and differentiation as well as immune and inflammatory responses.39,40 The STEM platform was also used to investigate how gene expression profiles change with tensile frequency during the osteoblast differentiation of PDLSCs under cyclic tension. Eight trend profiles were noted as significant. Genes in these profiles were mainly enriched in the metabolic pathways, PI3K-Akt signaling pathway, cytokine-cytokine receptor interaction, and MAPK signaling pathway. The PI3K-Akt signaling pathway has been reported to be involved in the mechanical force-induced osteoblast differentiation of PDLSCs.41,42 The MAPK signaling pathway also have been found to participate in the mechano-transduction of PDLSCs.43,44

Genes in profile 0 showed a continuous downward trend from 0.1 Hz to 0.7 Hz, an inverse trend of osteogenic genes, and were mainly enriched for pathways related to an inflammatory response, such as arachidonic acid metabolism and cytokinecytokine receptor interaction. Cyclooxygenase-2 (COX2) and prostaglandin E synthase (PTGES) participate in the arachidonic acid metabolism pathway. TNF Receptor Superfamily Member 14 (TNFRSF14) and Interleukin 9 (IL9) are involved in the cytokinecytokine receptor interaction. PTGES is induced by inflammatory mediators.45 COX2 is involved in the synthesis of prostaglandin E2 (PGE2), which is a potent pro-inflammatory cytokine, and participates in bone resorption.2 The expression of COX2 and PGE2 after mechanical stimulation was previously reported to be correlated with force duration and force magnitude,9 and it showed a negative correlation with tensile frequency in the present study. TNFRSF14 is a membrane-bound receptor leading to the induction of proinflammatory genes by activating the NF-B pathway.46 IL-9 plays a role in regulating inflammatory immunity, and it has demonstrated pro-inflammatory activity in several mouse models of inflammation.47 The response of periodontal ligament to mechanical stress generated by OTM is known as an aseptic transitory inflammatory process, which is regulated by various cytokines and chemokines.48 Proinflammatory cytokines activate matrix metalloproteinases (MMPs), degrade the ECM, and inhibit the expression of COL-I.49 Increased osteogenesis is usually accompanied by lower levels of inflammatory cytokines and chemokines.10,50,51 Accordingly, in the present study, with increasing frequency, the osteogenic commitment increased, and the suppression of pro-inflammatory genes and the relative inflammatory response pathway were observed.

Furthermore, through PPI network screening, we identified two candidate genes, EYA1 and SALL1, which were specifically sensitized to tensile frequency. The result was validated by RTqPCR, which confirmed the decreased expression of EYA1 and SALL1 with increasing frequency of tension stimulation. EYA1 is a conserved critical regulator of organ-specific stem cells.52 SALL1 is also considered a stem cell marker.53 The osteoblastic differentiation of PDLSCs increased with increasing tensile frequency; thus, stemness and related genes correspondingly reduced. In view of the high-throughput sequencing and validation after 6 h of tensile force exposure, further studies over a longer period are needed. Whether overexpression of EYA1 and SALL1 would reverse the frequency-dependent trend of the osteogenic differentiation of PDLSCs also deserves further study.

In the present study, the role of tensile frequency on osteogenic commitment of PDLSCs were identified, and the mRNA transcriptomes of PDLSCs during the osteogenic differentiation under cyclic tension with different frequencies were delineated. Frequency series clustering were defined using STEM, and tensile frequency-sensitive genes were identified. This study extends the knowledge about the role of tensile frequency in cyclic tension induced PDLSCs osteogenesis.

The osteoblastic differentiation of PDLSCs under mechanical tensile force is frequency dependent. EYA1 and SALL1 were identified as potential important tensile frequency-sensitive genes, which may contribute to the cyclic tension-induced osteogenic differentiation of PDLSCs in a frequency-dependent manner.

Raw data of the performed RNA sequencing (RNA-seq) have been recorded in the SRA database with the SRA accession: PRJNA665587 (https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA665587). Other data in this study are available from the corresponding author Xi Chen upon request.

The study was performed in accordance with the principles stated in the Declaration of Helsinki and approved by the Medical Ethics Committee of the First Affiliated Hospital of Medical College of Xi an Jiaotong University (No: XJTU1AF2019LSK-078). Informed consent was obtained from all donors and their legal guardians involved in the study. Written informed consent was also obtained from the donors and their legal guardians to publish this paper.

All authors made a significant contribution to the work reported, whether in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

This research was funded by the Key Research and Development project of Shaanxi Province under Grant 2018SF-037.

The authors declare that they have no competing interests.

1. Wang H, Sun W, Ma J, Pan Y, Wang L, Zhang W. Polycystin-1 mediates mechanical strain-induced osteoblastic mechanoresponses via potentiation of intracellular calcium and Akt/-catenin pathway. PLoS One. 2014;9(3):e91730. doi:10.1371/journal.pone.0091730

2. Li M, Zhang C, Yang Y. Effects of mechanical forces on osteogenesis and osteoclastogenesis in human periodontal ligament fibroblasts: a systematic review of in vitro studies. Bone Joint Res. 2019;8(1):1931. doi:10.1302/2046-3758.81.Bjr-2018-0060.R1

3. Chang M, Lin H, Fu H, Wang B, Han G, Fan M. MicroRNA-195-5p regulates osteogenic differentiation of periodontal ligament cells under mechanical loading. J Cell Physiol. 2017;232(12):37623774. doi:10.1002/jcp.25856

4. Yang Y, Wang BK, Chang ML, Wan ZQ, Han GL. Cyclic stretch enhances osteogenic differentiation of human periodontal ligament cells via YAP activation. Biomed Res Int. 2018;2018:2174824. doi:10.1155/2018/2174824

5. Jin SS, He DQ, Wang Y, et al. Mechanical force modulates periodontal ligament stem cell characteristics during bone remodelling via TRPV4. Cell Prolif. 2020;53(10):e12912. doi:10.1111/cpr.12912

6. Katz S, Boland R, Santilln G. Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: involvement of mechanical stress-activated calcium influx, PKC and Src activation. Int J Biochem Cell Biol. 2006;38(12):20822091. doi:10.1016/j.biocel.2006.05.018

7. Ren D, Wei F, Hu L, Yang S, Wang C, Yuan X. Phosphorylation of Runx2, induced by cyclic mechanical tension via ERK1/2 pathway, contributes to osteodifferentiation of human periodontal ligament fibroblasts. J Cell Physiol. 2015;230(10):24262436. doi:10.1002/jcp.24972

8. Xu J, Li Z, Hou Y, Fang W. Potential mechanisms underlying the Runx2 induced osteogenesis of bone marrow mesenchymal stem cells. Am J Transl Res. 2015;7(12):25272535.

9. Sun C, Janjic Rankovic M, Folwaczny M, Otto S, Wichelhaus A, Baumert U. Effect of tension on human periodontal ligament cells: systematic review and network analysis. Front Bioeng Biotechnol. 2021;9:695053. doi:10.3389/fbioe.2021.695053

10. Sun C, Janjic Rankovic M, Folwaczny M, et al. Effect of different parameters of in vitro static tensile strain on human periodontal ligament cells simulating the tension side of orthodontic tooth movement. Int J Mol Sci. 2022;23(3). doi:10.3390/ijms23031525

11. Natali AN, Pavan PG, Scarpa C. Numerical analysis of tooth mobility: formulation of a non-linear constitutive law for the periodontal ligament. Dent Mater. 2004;20(7):623629. doi:10.1016/j.dental.2003.08.003

12. Pinkerton MN, Wescott DC, Gaffey BJ, Beggs KT, Milne TJ, Meikle MC. Cultured human periodontal ligament cells constitutively express multiple osteotropic cytokines and growth factors, several of which are responsive to mechanical deformation. J Periodontal Res. 2008;43(3):343351. doi:10.1111/j.1600-0765.2007.01040.x

13. Liu J, Li Q, Liu S, et al. Periodontal ligament stem cells in the periodontitis microenvironment are sensitive to static mechanical strain. Stem Cells Int. 2017;2017:1380851. doi:10.1155/2017/1380851

14. Tang N, Zhao Z, Zhang L, et al. Up-regulated osteogenic transcription factors during early response of human periodontal ligament stem cells to cyclic tensile strain. Arch Med Sci. 2012;8(3):422430. doi:10.5114/aoms.2012.28810

15. Tantilertanant Y, Niyompanich J, Everts V, Supaphol P, Pavasant P, Sanchavanakit N. Cyclic tensile force stimulates BMP9 synthesis and in vitro mineralization by human periodontal ligament cells. J Cell Physiol. 2019;234(4):45284539. doi:10.1002/jcp.27257

16. Shen T, Qiu L, Chang H, et al. Cyclic tension promotes osteogenic differentiation in human periodontal ligament stem cells. Int J Clin Exp Pathol. 2014;7(11):78727880.

17. Wu X, Li Y, Cao Z, Xie Y, Fu C, Chen H. Mechanism of cyclic tensile stress in osteogenic differentiation of human periodontal ligament stem cells. Calcif Tissue Int. 2021;108(5):640653. doi:10.1007/s00223-020-00789-x

18. Wang Y, Hu B, Hu R, et al. TAZ contributes to osteogenic differentiation of periodontal ligament cells under tensile stress. J Periodontal Res. 2020;55(1):152160. doi:10.1111/jre.12698

19. Wang H, Feng C, Li M, Zhang Z, Liu J, Wei F. Analysis of lncRNAs-miRNAs-mRNAs networks in periodontal ligament stem cells under mechanical force. Oral Dis. 2021;27(2):325337. doi:10.1111/odi.13530

20. Yang L, Yang Y, Wang S, Li Y, Zhao Z. In vitro mechanical loading models for periodontal ligament cells: from two-dimensional to three-dimensional models. Arch Oral Biol. 2015;60(3):416424. doi:10.1016/j.archoralbio.2014.11.012

21. Hsieh YF, Turner CH. Effects of loading frequency on mechanically induced bone formation. J Bone Miner Res. 2001;16(5):918924. doi:10.1359/jbmr.2001.16.5.918

22. Scheuren AC, Vallaster P, Kuhn GA, et al. Mechano-regulation of trabecular bone adaptation is controlled by the local in vivo environment and logarithmically dependent on loading frequency. Front Bioeng Biotechnol. 2020;8:566346. doi:10.3389/fbioe.2020.566346

23. Yang SY, Wei FL, Hu LH, Wang CL. PERK-eIF2-ATF4 pathway mediated by endoplasmic reticulum stress response is involved in osteodifferentiation of human periodontal ligament cells under cyclic mechanical force. Cell Signal. 2016;28(8):880886. doi:10.1016/j.cellsig.2016.04.003

24. Borodina T, Adjaye J, Sultan M. A strand-specific library preparation protocol for RNA sequencing. Methods Enzymol. 2011;500:7998. doi:10.1016/b978-0-12-385118-5.00005-0

25. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8

26. Ernst J, Bar-Joseph Z. STEM: a tool for the analysis of short time series gene expression data. BMC Bioinform. 2006;7:191. doi:10.1186/1471-2105-7-191

27. Brulois K, Rajaraman A, Szade A, et al. A molecular map of murine lymph node blood vascular endothelium at single cell resolution. Nat Commun. 2020;11(1):3798. doi:10.1038/s41467-020-17291-5

28. Stanton BZ, Hodges C, Calarco JP, et al. Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin. Nat Genet. 2017;49(2):282288. doi:10.1038/ng.3735

29. Beauchaine TP, Beauchaine RJ. A comparison of maximum covariance and K-means cluster analysis in classifying cases into known taxon groups. Psychol Methods. 2002;7(2):245261. doi:10.1037/1082-989x.7.2.245

30. Iacono G, Dubos A, Mziane H, et al. Increased H3K9 methylation and impaired expression of Protocadherins are associated with the cognitive dysfunctions of the Kleefstra syndrome. Nucleic Acids Res. 2018;46(10):49504965. doi:10.1093/nar/gky196

31. Tantilertanant Y, Niyompanich J, Everts V, Supaphol P, Pavasant P, Sanchavanakit N. Cyclic tensile force-upregulated IL6 increases MMP3 expression by human periodontal ligament cells. Arch Oral Biol. 2019;107:104495. doi:10.1016/j.archoralbio.2019.104495

32. Symmank J, Zimmermann S, Goldschmitt J, et al. Mechanically-induced GDF15 secretion by periodontal ligament fibroblasts regulates osteogenic transcription. Sci Rep. 2019;9(1):11516. doi:10.1038/s41598-019-47639-x

33. Yu N, Prodanov L, Te Riet J, et al. Regulation of periodontal ligament cell behavior by cyclic mechanical loading and substrate nanotexture. J Periodontol. 2013;84(10):15041513. doi:10.1902/jop.2012.120513

34. Wei FL, Wang JH, Ding G, et al. Mechanical force-induced specific MicroRNA expression in human periodontal ligament stem cells. Cells Tissues Organs. 2014;199(56):353363. doi:10.1159/000369613

35. Jnsson D, Nebel D, Bratthall G, Nilsson BO. The human periodontal ligament cell: a fibroblast-like cell acting as an immune cell. J Periodontal Res. 2011;46(2):153157. doi:10.1111/j.1600-0765.2010.01331.x

36. Livne A, Bouchbinder E, Geiger B. Cell reorientation under cyclic stretching. Nat Commun. 2014;5:3938. doi:10.1038/ncomms4938

37. Rather HA, Jhala D, Vasita R. Dual functional approaches for osteogenesis coupled angiogenesis in bone tissue engineering. Mater Sci Eng C Mater Biol Appl. 2019;103:109761. doi:10.1016/j.msec.2019.109761

38. Jacobs C, Grimm S, Ziebart T, Walter C, Wehrbein H. Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain. Arch Oral Biol. 2013;58(7):896904. doi:10.1016/j.archoralbio.2013.01.009

39. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296(5573):16341635. doi:10.1126/science.1071924

40. Arden KC. FoxO: linking new signaling pathways. Mol Cell. 2004;14(4):416418. doi:10.1016/s1097-2765(04)00213-8

41. Qi L, Zhang Y. The microRNA 132 regulates fluid shear stress-induced differentiation in periodontal ligament cells through mTOR signaling pathway. Cell Physiol Biochem. 2014;33(2):433445. doi:10.1159/000358624

42. Jiang N, He D, Ma Y, et al. Force-induced autophagy in periodontal ligament stem cells modulates M1 macrophage polarization via AKT signaling. Front Cell Dev Biol. 2021;9:666631. doi:10.3389/fcell.2021.666631

43. Ziegler N, Alonso A, Steinberg T, et al. Mechano-transduction in periodontal ligament cells identifies activated states of MAP-kinases p42/44 and p38-stress kinase as a mechanism for MMP-13 expression. BMC Cell Biol. 2010;11:10. doi:10.1186/1471-2121-11-10

44. Tang M, Peng Z, Mai Z, et al. Fluid shear stress stimulates osteogenic differentiation of human periodontal ligament cells via the extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling pathways. J Periodontol. 2014;85(12):18061813. doi:10.1902/jop.2014.140244

45. Blair PJ, Hwang SJ, Shonnard MC, et al. The role of prostaglandins in disrupted gastric motor activity associated with type 2 diabetes. Diabetes. 2019;68(3):637647. doi:10.2337/db18-1064

46. Shui JW, Steinberg MW, Kronenberg M. Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling. J Leukoc Biol. 2011;89(4):517523. doi:10.1189/jlb.0910528

47. Goswami R, Kaplan MH. A brief history of IL-9. J Immunol. 2011;186(6):32833288. doi:10.4049/jimmunol.1003049

48. Lee SI, Park KH, Kim SJ, Kang YG, Lee YM, Kim EC. Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells. Clin Exp Immunol. 2012;168(1):113124. doi:10.1111/j.1365-2249.2011.04549.x

49. Sun C, Liu F, Cen S, et al. Tensile strength suppresses the osteogenesis of periodontal ligament cells in inflammatory microenvironments. Mol Med Rep. 2017;16(1):666672. doi:10.3892/mmr.2017.6644

50. Loi F, Crdova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB. Inflammation, fracture and bone repair. Bone. 2016;86:119130. doi:10.1016/j.bone.2016.02.020

51. Orapiriyakul W, Tsimbouri MP, Childs P, et al. Nanovibrational stimulation of mesenchymal stem cells induces therapeutic reactive oxygen species and inflammation for three-dimensional bone tissue engineering. ACS Nano. 2020;14(8):1002710044. doi:10.1021/acsnano.0c03130

52. Sun Y, Kaneko S, Li XK, The LX. PI3K/Akt signal hyperactivates Eya1 via the SUMOylation pathway. Oncogene. 2015;34(19):25272537. doi:10.1038/onc.2014.179

53. Griesche N, Luttmann W, Luttmann A, Stammermann T, Geiger H, Baer PC. A simple modification of the separation method reduces heterogeneity of adipose-derived stem cells. Cells Tissues Organs. 2010;192(2):106115. doi:10.1159/000289586

Read more:
Effect of tensile frequency on osteogenic differentiation | IJGM - Dove Medical Press

Posted in Utah Stem Cells | Comments Off on Effect of tensile frequency on osteogenic differentiation | IJGM – Dove Medical Press

Paolo Macchiarini – Wikipedia

Posted: July 3, 2022 at 2:25 am

Swiss-born Italian physician

Paolo Macchiarini (born 22 August 1958)[1]:2 is a Swiss-born Italian thoracic surgeon and former regenerative medicine researcher who became known for research fraud and manipulative behavior.[2][3]

Previously considered a pioneer for using both biological and synthetic scaffolds seeded with patients' own stem cells as trachea transplants, Macchiarini was a Visiting Professor and Director on a temporary contract at Sweden's Karolinska Institutet (KI) from 2010.[4] Macchiarini has been accused of unethically performing experimental surgeries, even on relatively healthy patients, resulting in fatalities for seven of the eight patients who received one of his synthetic trachea transplants.[5] Articles in Vanity Fair and Aftonbladet further suggested that he had falsified some of his academic credentials on rsums.[6][7]

Urban Lendahl[sv], the secretary of the Nobel Committee for Physiology or Medicine, resigned in February 2016, owing to his involvement in recruiting Macchiarini to KI.[8]Shortly afterwards KI's vice chancellor, Anders Hamsten[sv], who in 2015 had cleared Macchiarini of misconduct, also resigned.[9] KI terminated its clinical relationship with Macchiarini in 2013 but allowed him to continue as a researcher; in February 2016, the university announced that it would not renew his research contract, which was due to expire in November, and terminated the contract the following month.[10] After being dismissed from KI, Macchiarini worked at the Kazan Federal University in Russia until that institution terminated his project in April 2017, effectively firing him.[11][12]

After a one-year medico-legal investigation, the Swedish Prosecution Authority announced in October 2017 that Macchiarini had been negligent in four of the five cases investigated due to the use of devices and procedures not supported by evidence, but that a crime could not be proven because the patients might have died under any other treatment given.[13][14] Also in October, Sweden's Expert Group on Scientific Misconduct found evidence of research fraud by Macchiarini and his co-authors in six papers and called for them to be retracted.[15] As of 2020, Macchiarini has had eight of his research papers retracted, and two have received an expression of concern.[16]

Paolo Macchiarini obtained his medical degree (equivalent to MD) at the Medical School of the University of Pisa (UniPi) in 1986 and a Master of Surgery in 1991.[17] He was an assistant professor at UniPi from 1990 to 1992.[17] He took a course on statistics in clinical research at University of Alabama at Birmingham in 1989.[17] Macchiarini obtained degree certificatesa masters in organ and tissue transplantation dated 1994 and a doctorate in the same dated 1997from University of Franche-Comt in France.[17] According to Germany's Hannover Medical School, he never had a salaried position there, but was head of the department of thoracic and vascular surgery at the Heidehaus Hanover hospital between 1999 and 2004.[17] Macchiarini was an investigator at the Institut d'Investigacions Biomdiques-Instituto de Investigaciones Biomdicas in Barcelona, Spain, from 2006 to 2009; he was affiliated with but not an employee of the University of Barcelona and was apparently an employee at the Hospital Clnic de Barcelona during this time.[17] He had an honorary appointment as a Visiting Professor from 2009 to 2014, at University College London.[17] He was a consultant and project manager at University Hospital Careggi (AOUC) starting in 2010.[17]

Later in 2010, Macchiarini was appointed as a visiting professor at the Karolinska Institute (KI) in Stockholm and as a part-time position as surgeon at the affiliated university hospital.[17] In 2013, KI terminated its clinical relationship with Macchiarini but allowed him to continue as a researcher; in February 2016, the university announced that it would not renew Macchiarini's research contract, which was due to expire in November, and terminated the contract the following month.[10][18] KI published the incomplete results of its verification of Macchiarini's CV in February 2016.[17]

Macchiarini made ties in Russia after he gave a master class in 2010, at the invitation of politician Mikhail Batin; a few months later he did a trachea transplant there which was widely covered in Russian media.[12] This led to Macchiarini's 2011 appointment at Kuban State Medical University, funded by the university and the Russian government,[12] along with an honorary doctorate.[17] In 2016, he moved to Kazan Federal University and the grant money moved with him.[12] In April 2017, the university terminated Macchiarini's research project there.[12]

In June 2008, Macchiarini conducted a transplant of a donated trachea colonized with the stem cells of the recipient, Claudia Castillo; the tissue was used to replace her left bronchus, which had been damaged by tuberculosis, and her left lung had collapsed.[19] The trachea came from a cadaver, and was stripped of its cells and seeded with cells taken from Castillo's bone marrow.[19][20][21] The bone marrow cells were cultured at the University of Bristol, the donor trachea was stripped at University of Padua, the stripped trachea was seeded with the cultured cells at University of Milan, and the trachea was transplanted by a team led by Macchiarini at Hospital Clinic in Barcelona.[19][22]

In March 2010, Macchiarini attended a transplant performed by Great Ormond Street surgeons. Similar to the one done for Castillo, on a ten-year-old Irish boy, Ciaran Finn-Lynch, at Great Ormond Street Hospital in London.[23] The boy was born with a 1mm diameter trachea, and efforts to widen it had caused life-threatening complications.[23] Unlike the Castillo procedure, in this case, the stripped trachea was seeded with the boy's stem cells just hours before it was implanted.

Keziah Shorten had trachea cancer. In 2010, Macchiarini performed a transplant similar to the earlier two; the transplant failed the next year, and a synthetic trachea was implanted for palliative care at University College Hospital London in 2011, after which she was able to be discharged and return home for Christmas with her family before succumbing to her underlying disease.[24]

In 2010, Macchiarini implanted a seeded donated trachea in a woman in Russia, while working with surgeon Vladimir Parshin.[12][25][26]

Andemariam Teklesenbet Beyene was a man from Eritrea who was earning a master's degree in Iceland when he was diagnosed with cancer; the cancer was treated with chemotherapy and surgery in 2009, but in 2011 his trachea was obstructed again. Beyene's doctors recommended palliative care, but also reached out to Macchiarini, who was at KI by that time.[27]:8 In this case, Macchiarini collaborated with scientists at University College London to manufacture a fully synthetic trachea, with an engineered scaffold seeded with Beyene's marrow cells, instead of using a donated and stripped trachea, as it had been done before.[24] The operation occurred in June 2011 and was widely covered in the media, including a front page story in The New York Times.[28] By end of the year the implant was failing, and while Beyene was able to complete his Ph.D in 2012, he died in January 2013 despite undergoing many treatments at KI.[27]:8 The autopsy showed that Beyene had a chronic lung infection, a clot in his lung, and the synthetic trachea had come loose.[27]:8

Christopher Lyles lived in the United States; he had tracheal cancer which was treated with radiation and surgery. He heard about Beyene's treatment and through his doctor asked Macchiarini to do the same for him. Macchiarini obliged, creating a fully synthetic trachea seeded with stem cells from Lyles and implanting it at KI in November 2011.[27]:9 Lyles died suddenly in 2012 after he had returned home; no autopsy was performed.[27]:9[29]

In June 2012, Macchiarini implanted a fully synthetic seeded trachea in Yulia Tuulik at Kuban State Medical University; Tuulik had a tracheostomy resulting from a car accident, but her life was not in danger.[12][30] The graft included a cricoid cartilage, part of the voice box, which Macchiarini had not tried before.[30] The trachea later collapsed, and was replaced; she died in 2014.[12] An audit by the Russian government later found that Macchiarini had operated without a Russian medical license.[12]

Also in June 2012, Macchiarini implanted a second synthetic seeded trachea on Alexander Zozulya, who also had a tracheostomy resulting from a car accident and whose life was not in danger.[12][24][30] The effects from the first implant in 2012 prompted a second surgery in November 2013. Zozulya died in February 2014 under unclear circumstances.[24]

Turkish national Yesim Cetir underwent a routine surgery in 2011 to treat excessive sweating in her hands, but due to an error her trachea was severely injured and her left lung was damaged.[24][27]:9 She came to Macchiarini at the KI for treatment, and in 2012 he first removed her left lung and replaced her trachea with a pipe, then replaced the pipe with a fully synthetic seeded trachea.[27]:9 The next year the implant collapsed and Macchiarini replaced it with a second one.[27]:9 Cetir had many complications from this procedure, remained in constant need of having her airway cleared, and suffered kidney failure.[27]:9 In 2016 she underwent multiple organ transplants in the U.S., and her trachea was replaced with one from a cadaver.[27]:9 Cetir died in March 2017.[31]

In April 2013, Macchiarini implanted a fully synthetic seeded trachea in two-year-old Hannah Warren, who had been born without one.[32] The operation was performed at OSF Saint Francis Medical Center in Peoria, Illinois, United States.[32] The operation also involved her esophagus, which didn't heal properly and required a second operation in June; she died 6 July 2013, from complications of the second surgery.[33]

In August 2013 Sadiq Kanaan received a fully synthetic seeded tracheal implant from Macchiarini at Kuban State Medical University.[11][24] He died later the same year.[11]

In June 2014, Macchiarini implanted a fully synthetic seeded trachea in Dmitri Onogda at the Kuban State Medical University.[11][24] The implant failed and was replaced, and as of 2017 Onogda was still alive.[11][24]

In 2012, Macchiarini was arrested in Italy and charged with asking patients at AOUC for money to expedite their procedures;[34] the charges were dismissed in May 2015[35] and the prosecutor's appeal was dismissed in September 2015.[36]

In 2014, Macchiarini was accused by four former colleagues and co-authors of having falsified claims in his research with KI.[37] The following April, KI's ethics committee issued a response to one set of allegations with regard to research ethics and peer review at The Lancet, and found them to be groundless.[38]

KI had also appointed an external expert, Bengt Gerdin, to review the charges, comparing the results reported to the medical record of the hospital; the report was released by the university in May 2015.[39][40][41] Gerdin found that Macchiarini had committed research misconduct in seven papers by not getting ethical approval for the some of his operations, and misrepresenting the result of some of those operations, as well as work he had done in animals.[39][40][42]

In August 2015, after considering the findings and a rebuttal provided by Macchiarini, KI vice-chancellor Anders Hamsten found that he had acted "without due care" but had not committed misconduct.[43][44] The Lancet, which published Macchiarini's work, also published an article defending him.[45]

On 13 January 2016, Gerdin criticized the vice-chancellor's dismissal of the allegations in an interview with Sveriges Television (SVT).[46] Later that day, the SVT investigative program Dokument inifrn began broadcasting a three-part series, titled "Experimenten", in which Macchiarini's work was investigated.[47][48] The documentary shows Macchiarini continuing operations with his new transplant method even after it showed little or no promise, exaggerating the health of his patients in articles as they died. While Macchiarini admitted that the synthetic trachea did not work in the current state, he did not agree that trying it on several additional patients without further testing had been inappropriate. Allegations were also made that patients' medical conditions both before and after the operations, as reported in academic papers, did not match reality. Macchiarini also stated that the synthetic trachea had been tested on animals before using it on humans, something that could not be verified.[10][18][24]

On 28 January, KI issued a statement saying that the documentary made claims of which it was unaware, and that it would consider re-opening the investigations.[49][50] These concerns were echoed by KI's chairman, Lars Leijonborg, and the chairman of the Swedish Medical Association, Heidi Stensmyren, calling for an independent investigation that would also look at how the issue was dealt with by the university and hospital management.[51]

In February 2016, KI published a review of Macchiarini's CV that identified discrepancies.[17] The university announced that it would not renew Macchiarini's research contract, which was due to expire in November, and the next month Karolinska terminated the contract.[10]

In October 2016, the BBC broadcast a three-part Storyville documentary, Fatal Experiments: The Downfall of a Supersurgeon, directed by Bosse Lindquist and based on the earlier Swedish programmes about Macchiarini.[52] After the special aired, KI requested Sweden's national scientific review board to review six of Macchiarini's publications about the procedures. The board published its findings in October 2017, and concluded that all six were the result of scientific misconduct, in particular by failing to report the complications and deaths that occurred after the interventions; one of the articles also claimed that the procedure had been approved by an ethics committee, when this had not happened. The board called for all six of the papers to be retracted. It also said that all of the co-authors had committed scientific misconduct as well.[15]

The following papers authored by Macchiarini have been retracted:

A story published by Vanity Fair on 5 January 2016 discussed Macchiarini's affair with a journalist, who had written enthusiastic articles about him. The story also called into question statements he had made on his CV.[47][6] The article paints him as a serial fabulist, and as "the extreme form of a con man," remarking that "the fact that he could keep all the details straight and compartmentalize these different lives and lies is really amazing."[6] The article details a courtship and alleged subsequent marriage arrangements from the perspective of a NBC News producer, Benita Alexander. Alexander had been tasked by NBC News to produce a documentary-type programme for Dateline in 2013 called "A Leap of Faith" to portray Macchiarini and she ultimately began an affair with her subject, only to find out later in 2015 that he had been married for thirty years, including the entire period of the courtship. The details recounted in the article include Alexander relating Macchiarini's alleged lies about being a surgeon to the stars and current and former heads of state, and a planned wedding to Alexander to be the social event of the year (with Pope Francis officiating, Andrea Bocelli singing, Enoteca Pinchiorri catering, and numerous celebrities attending), among other reported falsified details about his C.V. and personal life.[6]

Macchiarini is reported to have claimed that Pope Francis had given his personal blessing for the wedding between the couple, both said to be divorcees, and would host the ceremony. The Pope's spokesman said that the Pope had no "personal doctor" named Macchiarini, knew nobody of that name, and would not have officiated.[60]

In August 2021, the third season of the Dr. Death podcast began publishing episodes consisting a six-episode season about Macchiarini, entitled "Miracle Man". The audio series covers the accusations of ethical misconduct and manipulation in Macchiarini's medical work alongside those of his personal deceit in his affair with Alexander, told through a series of interviews with the latter.[61]

The secretary of the Nobel Committee for Physiology or Medicine, Urban Lendahl, resigned in February 2016, owing to his involvement in recruiting Macchiarini to Karolinska Institutet in 2010.[8][62] Shortly afterwards the vice chancellor, Anders Hamsten, who in 2015 had cleared Macchiarini of scientific misconduct, also resigned.[9][63]

In August 2016, a committee led by Kjell Asplund that had been called into being in February to investigate the three operations that Macchiarini had performed at the Karolinska University Hospital issued its report, identifying several ethical shortcomings by the hospital and Macchiarini; it also noted the pressure put on the hospital by the institute with regard to Macchiarini's hospital appointment and translational research.[27][64]

Another report was issued in early September that examined the behavior of the institute; it was authored by a committee led by Sten Heckscher. The report found that the institute had conducted almost no diligence in hiring Macchiarini nor in overseeing his work, nor in considering his performance in reviewing his contracts; the committee found that interference from people higher up in management had interfered in the processes.[64][65][66]

On 5 September 2016, the Swedish government moved to dismiss the entire board of the Institute.[67] Shortly afterwards Harriet Wallberg and Anders Hamsten were removed from the judging panel that is responsible for annually choosing the Nobel Prize for Medicine, selection of which is additionally overseen by Karolinska Institutet.[68]

In June 2016 Swedish police opened an investigation into whether Macchiarini might have committed involuntary manslaughter.[11][24] In October 2017, the public prosecutor office announced that all criminal charges against Macchiarini have been dropped, although the medical treatment in four of five cases operated in Sweden was classified as 'negligent' the criminal responsibility cannot be proven.[69] After a one-year medico-legal investigation, the attorney general's office announced in October 2017 that Macchiarini had been negligent in four of the five cases investigated due to the use of devices and procedures not supported by evidence, but that a crime could not be proven because the patients might have died under any other treatment given.[13][14]

In 2019, an Italian court sentenced Macchiarini to sixteen months in prison for abuse of office and forging documents.[70]

On 29 September 2020, Mikael Bjork, director of Public Prosecution in Sweden indicted an unnamed surgeon on charges of aggravated assault. Swedish news agency TT said the indicted surgeon was Dr. Paolo Macchiarini. Bjork said he reopened the investigation in December 2018 and obtained new written evidence and interviewed individuals in five different countries. Bjork said victims received "serious physical injuries and great suffering" as a result of the operations performed on them and that he "made the assessment that the three operations are therefore to be considered as aggravated assault."[70] The trial against Paolo Macchiarini ended on 23 May 2022, and he was found guilty to having caused bodily harm, but not assault. He was received a probationary sentence on 16 June 2022.[71][72]

Here is the original post:
Paolo Macchiarini - Wikipedia

Posted in Alabama Stem Cells | Comments Off on Paolo Macchiarini – Wikipedia

President Freeman Hrabowski prepares for retirement after turning UMBC into the top producer of Black M.D., Ph.D. graduates – Afro American

Posted: July 3, 2022 at 2:25 am

By Megan Sayles, AFRO Business Writer, Report for America Corps Member, msayles@afro.com

President Freeman Hrabowski III has led the University of Maryland, Baltimore County (UMBC), since 1992. After decades of revolutionary leadership, the giant of higher education announced his retirement.

In spite of his profound adoration for the school and its students, Hrabowski is ready for his next chapter in which he will mentor new presidents and provosts at Harvard University. He will also support the Howard Hughes Medical Institutes novel, billion-dollar program to produce more scientists of color.

The program was named after Hrabowski, a privilege he deemed inconceivable.

For a Black kid who went to jail with Dr. King and didnt know what was going to happen, this is an honor I could have never imagined, said Hrabowski.

Born in Birmingham, Ala., Hrabowski grew up in a middle-class family. His parents were teachers, meaning he grew up as privileged as a Black kid could be during the 1950s and 60s in the Deep South.

Living separate but equal, he couldnt go through certain doors, eat-in certain restaurants, or drink out of certain water fountains, but his parents time and time again instructed him to never let anyone else define who he was.

When Hrabowski was 12 years old, he marched in the Birmingham Childrens Crusade. He along with thousands of other youth were taken to jail for their efforts to protest against segregation.

During his week in jail, Hrabowski looked out his cells window and wondered, will I be OK? The experience was a turning point for him.

Hrabowski became the poster child for the Civil Rights Movement in Birmingham, giving speeches in churches, NAACP meetings, Alabama Christian Movement meetings, and to Black sororities and fraternities.

While his dedication to civil rights never ceased, Hrabowski had another passion: mathematics.

He was a gifted student and dreamed of becoming a math teacher one day because doing arithmetic gave him goosebumps.

His parents were proud graduates of Tuskegee University, and Hrabowski spent much of his time at the campus, which showed him how nurturing historically Black colleges and universities (HBCUs) are.

He knew he had to attend an HBCU after taking summer courses in Massachusetts. There, Hrabowski was the invisible man. His fellow students ignored him, and his teachers refused to speak to him.

At age 15, he attended Hampton University, in spite of his parents desire for him to enroll at Morehouse College, and he completed his undergraduate degree in mathematics at 18. He also met Jacqueline Coleman at the university. She has been his wife for 50 years.

Ever since he was young, Hrabowski wanted to earn a Ph.D., so after graduating from Hampton University, he attended the University of Illinois Urbana-Champaign where he received his masters in mathematics and then his doctorate in higher education administration.

At 26, Hrabowski became the dean of arts and sciences at Coppin State University and achieved his dream of teaching mathematics. He remained at the school for a decade and exited as vice president of academic affairs when former UMBC (University of Maryland, Baltimore County) President, Michael Hooker, offered him the opportunity to become the next provost.

Hrabowski was no stranger to the university, as his wife taught early childhood education and child psychology there. His first impression of the campus was that it was suburban, young and boasted an abundance of bright students.

After several years of serving as provost, he became president of the predominantly White institution.

Hrabowskis tenure as president can be distinguished by its emphasis on science, technology, engineering, and mathematics (STEM) education.

When he took office, UMBC students who studied the STEM disciplines, struggled to attain their degrees, and Black students faced even more challenges than their White counterparts.

He made it his mission to ensure all UMBC students have the ability to succeed in STEM.

Today, UMBC is a Research One (R1) university, the nations highest level of research performance. The school also graduates more Black students who go on to earn doctoral degrees in natural sciences and engineering than any other U.S. college. It is also the number one institution to produce Black graduates who go on to earn M.D. and Ph.D.s.

The Black graduation rates are as higher than any other institution, and half of our Black students are male, which is unheard of in American education, said Hrabowski.

His most cherished memories of UMBC involve witnessing former retrievers, the universitys mascot, excel in their careers.

Most notably, UMBC is credited for having the first Black woman to create a vaccine, Kissmekia Corbett. She was a student in the Meyerhoff Scholars Program, which was designed to prepare minority students for STEM disciplines, and graduated from the university in 2008.

During the COVID-19 pandemic, she played an instrumental role in the development of the Moderna vaccine.

Hrabowski said he hopes hes left a legacy at UMBC that students of all races can excel.

Valerie Sheares Ashby will become the universitys next president, the first woman to hold the position, and Hrabowski has no doubt that she will continue to propel the university forward.

Help us Continue to tell OUR Story and join the AFRO family as a member subscribers are now members! Joinhere!

Read more here:
President Freeman Hrabowski prepares for retirement after turning UMBC into the top producer of Black M.D., Ph.D. graduates - Afro American

Posted in Alabama Stem Cells | Comments Off on President Freeman Hrabowski prepares for retirement after turning UMBC into the top producer of Black M.D., Ph.D. graduates – Afro American